Search
for

    Sort by

    Research 31–60 of 1000+

    1. Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients Afro-Egyptian Journal of Infectious and Endemic Diseases · 2016
    2. Resident macrophages of the lung and liver: The guardians of our tissues Frontiers in Immunology · 2022 · 4 citations
    3. 만성 B형 간염 환자에서 Pegylated 인터페론 알파2a 치료 중 발생한 원형 탈모 대한피부과학회지 · 2014
    4. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis Clinical and Molecular Hepatology · 2016 · 12 citations
    5. Hepatitis C Treatment and Alopecia Totalis Journal of Investigative Dermatology Symposium Proceedings · 2013 · 8 citations
    6. Psoriasis and Hepatitis C: Improvement with Interferon 2011
    7. Drug-induced postinfantile giant cell hepatitis Hepatology · 2010 · 10 citations
    8. Segmental Vitiligo and Hair Curling After Interferon α and Ribavirin Treatment for Hepatitis C Skinmed · 2006 · 14 citations
    9. Finasteride and Methadone Use and Risk of Advanced Hepatitis C Related Liver Disease Digestive Diseases and Sciences · 2012 · 2 citations
    10. A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary report Journal of Gastroenterology and Hepatology · 1993 · 17 citations
    11. High-Dose Vitamin D3 and Tonsillectomy as Therapeutic Management in Henoch-Schönlein Purpura Following Hepatitis B Vaccination: A Rare Case Report. PubMed · 2024
    12. Alopecia universalis following interferon alfa-2b and ribavirin treatment for hepatitis C. PubMed · 2007 · 4 citations
    13. Alopecias Springer eBooks · 2015
    14. Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis The Scientific World Journal · 2014 · 291 citations
    15. Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects Expert Opinion on Drug Safety · 2011 · 17 citations
    16. Clinico-Epidemiological Aspects of Cutaneous Lesions in Injecting Drug Users Visiting an Oral Substitution Therapy Centre: A Cross-Sectional Study Dermatology practical & conceptual · 2022
    17. Widespread Dystrophic-Anagen Alopecia and Drug Eruption due to Usage of PEG-IFN ?-2a /Ribavirin Combination Therapy Hair therapy & transplantation · 2014 · 1 citations
    18. Cutaneous necrosis after injection of polyethylene glycol–modified interferon alfa Journal of The American Academy of Dermatology · 2005 · 26 citations
    19. P23 A case of visceral leishmaniasis presenting as seropositive erosive rheumatoid arthritis in an immunocompromised patient Rheumatology Advances in Practice · 2024
    20. Hyperadrenocorticism in a ferret. PubMed · 1987 · 23 citations
    21. Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy Hepatitis Monthly · 2015 · 2 citations
    22. A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin Canadian Journal of Gastroenterology · 2009 · 64 citations
    23. An autopsy case of unicentric Castleman's disease associated with bronchiolitis obliterans Respirology Case Reports · 2014 · 5 citations
    24. Clinical case of manifestation of toxic keratitis with vitamin A intoxication Meditsinskiy sovet = Medical Council · 2024
    25. 861 Association between keloids and atopic dermatitis: a cross-sectional study at a tertiary care center 2019
    26. Abstracts of 42nd National Conference of Association of Clinical Biochemists of India (ACBICON 2015) Indian Journal of Clinical Biochemistry · 2015 · 1 citations
    27. Alopecia areata during Interferon Alpha-2b/Ribavirin Therapy Dermatology · 2002 · 35 citations
    28. Hepatology highlights Hepatology · 2004 · 1 citations
    29. Highlights Journal of the Formosan Medical Association · 2019
    30. Human placenta hydrolysates: from V.P. Filatov to the present day: Review Terapevticheskii arkhiv · 2022 · 9 citations